FINANCIAL NEWS
Untitled Page
Irvine-based Neomend raises $30 million
Funding supports surgical product developer's ProGEL technology.
By Ashley EliotPublished: January 27, 2010
Irvine-based Neomend Inc., a maker of surgical sealants and adhesion-prevention devices, has raised $30 million through its Series D funding round. The move supports the company's ProGEL sealant product.
Clarus Ventures, a life sciences venture capital firm, invested the majority – $17 million – of the funds. Sanderling Ventures, Novo Ventures, Vivo Ventures and Prospect Venture Partners also participated in the financing round.
The financial backing recognizes the "value" of ProGEL, according to Neomend President and CEO David Renzi.
NEXT PAGE >>>
Related stories
Aliso Viejo's Vertos Medical closes $15.5 million funding
Aliso Viejo's Cianna completes funding round for SAVI
Huntington Beach's Impact Medical rebrands as iTech Medical
Visual tech firm Christie enters the medical world
|
||||
|
Clarus Ventures, a life sciences venture capital firm, invested the majority – $17 million – of the funds. Sanderling Ventures, Novo Ventures, Vivo Ventures and Prospect Venture Partners also participated in the financing round. The financial backing recognizes the "value" of ProGEL, according to Neomend President and CEO David Renzi. NEXT PAGE >>> Related stories Aliso Viejo's Vertos Medical closes $15.5 million funding Aliso Viejo's Cianna completes funding round for SAVI Huntington Beach's Impact Medical rebrands as iTech Medical Visual tech firm Christie enters the medical world |
||||
